N/A
N=72
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access
Heart Diseases
Bottom Line
View on ClinicalTrials.gov: NCT01209260 ↗Enrolled (actual)
72
Serious AEs
2.8%
Results posted
Jan 2014
Primary outcome: Primary: Transseptal Access Procedure Time — 2.3; 7.3 minutes — p=0.005
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Radiofrequency energy needle (Device); Mechanical Needle (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of California, San Francisco
- Primary completion
- Nov 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Transseptal Access Procedure Time |
2.3; 7.3 | 0.005 sig |
| SECONDARY Number of Participants With Adverse Events as a Measure of Safety |
1; 1 | — |
| SECONDARY Performance of the Assigned Needle Type |
36; 26; 0; 10 | <0.001 sig |
| SECONDARY Plastic Dilator Shavings |
0; 12 | <0.001 sig |
Summary
This is a randomized controlled trial examining whether a mechanical needle versus a needle that uses radiofrequency energy is better at puncturing through a thin wall in the heart (called "transseptal puncture") as measured by procedure time, during an electrical procedure/study of the heart .
Eligibility Criteria
Inclusion Criteria
- Patients undergoing radiofrequency ablation within the left atrium through a transseptal approach
- Patients greater than 18 years of age
Exclusion Criteria
- Patients unable to grant informed, written consent
Data sourced from ClinicalTrials.gov (NCT01209260). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.